244 related articles for article (PubMed ID: 5066947)
21. A reconsideration of a thyroid-stimulating immunoglobulin as the cause of hyperthyroidism in Graves' disease.
McKenzie JM; Zakarija M
J Clin Endocrinol Metab; 1976 Apr; 42(4):778-81. PubMed ID: 177449
[TBL] [Abstract][Full Text] [Related]
22. Thyroid eye disease and its relationship to the long-acting thyroid stimulator.
Hollows FC; Beaumont P
Trans Aust Coll Ophthalmol; 1969; 1():37-44. PubMed ID: 4250318
[No Abstract] [Full Text] [Related]
23. Failure of long-acting thyroid stimulator globulin (LATS) and serum to stimulate thyroid function in the chick.
Lepp A; Oliner L
Endocrinology; 1967 Feb; 80(2):369-74. PubMed ID: 4163488
[No Abstract] [Full Text] [Related]
24. Pathogenesis of neonatal Graves' disease.
McKenzie JM; Zakarija M
J Endocrinol Invest; 1978 Apr; 1(2):183-9. PubMed ID: 385703
[No Abstract] [Full Text] [Related]
25. Four controversies about the cause of hyperthyroidism.
Lancet; 1979 Jul; 2(8133):78-80. PubMed ID: 87971
[No Abstract] [Full Text] [Related]
26. The role of long-acting thyroid stimulator and of thyroid autoimmunity in the pathogenesis of euthyroid endocrine ophthalmopathy.
Földes J; Takó J; Bános C; Gesztesi E
Acta Med Acad Sci Hung; 1971; 28(2):171-9. PubMed ID: 5172524
[No Abstract] [Full Text] [Related]
27. [Physiopathology of hyperthyroidism].
Miyai K; Fukuchi M; Amino N; Azukizawa M
Nihon Naibunpi Gakkai Zasshi; 1970 Jan; 45(10):1004-15. PubMed ID: 5467355
[No Abstract] [Full Text] [Related]
28. On the effect of thyrotropin and immunoglobulins related to Graves' disease on thyrotropin synthesis and secretion.
Dandona P; El Kabir DJ
Clin Endocrinol (Oxf); 1978 Oct; 9(4):321-7. PubMed ID: 581481
[No Abstract] [Full Text] [Related]
29. Experimental production of a thyroid-stimulating antithyroid antibody.
McKenzie JM
J Clin Endocrinol Metab; 1968 May; 28(5):596-602. PubMed ID: 4172455
[No Abstract] [Full Text] [Related]
30. [Immunopathogenic reactions of the thyroid gland and their importance for diagnosis].
Uthgenannt H
Internist (Berl); 1969 Aug; 10(8):321-2. PubMed ID: 4904082
[No Abstract] [Full Text] [Related]
31. [The long-acting thyroid stimulator (LATS)].
Masala C
Folia Allergol (Roma); 1969; 16(3):249-63. PubMed ID: 4931876
[No Abstract] [Full Text] [Related]
32. The interaction between thyroid tissue and the long-acting thyroid stimulator.
Kendall-Taylor P; Smith BR; Munro DS
Q J Med; 1971 Oct; 40(160):564-5. PubMed ID: 4110160
[No Abstract] [Full Text] [Related]
33. Long-acting thyroid stimulator and related factors.
Kendall-Taylor P; Dirmikis SM; Munro DS
Proc R Soc Med; 1975 Apr; 68(4):252-3. PubMed ID: 1242809
[No Abstract] [Full Text] [Related]
34. On the interaction of long-acting thyroid stimulator with thyroid microsomes.
Burke G
J Clin Endocrinol Metab; 1967 Aug; 27(8):1095-102. PubMed ID: 4166580
[No Abstract] [Full Text] [Related]
35. LATS and Graves' disease.
Soloman DH; Chopra IJ
Calif Med; 1970 Aug; 113(2):50-5. PubMed ID: 5538194
[No Abstract] [Full Text] [Related]
36. [Significance of long-acting thyroid stimulator. Reflections on the 1st series of results].
Tourneur R; Letonturier P; Sénécal P
Minerva Med; 1974 Mar; 65(19):995-8. PubMed ID: 4406464
[No Abstract] [Full Text] [Related]
37. [Graves-Basedow type ophthalmopathy and primary hypothyroidism].
Cathelineau G; Fribourg-Desi M
Nouv Presse Med; 1974 Sep; 3(32):1995-8. PubMed ID: 4372586
[No Abstract] [Full Text] [Related]
38. Correlation between long-acting thyroid stimulator protector level and thyroid 131-I uptake in thyrotoxicosis.
Adams DD; Kennedy TH; Stewart RD
Br Med J; 1974 Apr; 2(5912):199-201. PubMed ID: 4406686
[TBL] [Abstract][Full Text] [Related]
39. Humoral immunity in Graves' disease.
McKenzie JM; Zakarija M; Sato A
Clin Endocrinol Metab; 1978 Mar; 7(1):31-45. PubMed ID: 580600
[No Abstract] [Full Text] [Related]
40. [Radioreceptor assay of TSH].
Torizuka K; Konishi J; Endo K; Ikekubo K; Mori T
Nihon Rinsho; 1976; 34(3):471-6. PubMed ID: 778435
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
